ATE225768T1 - 1-(adamantyl)amidine und ihre verwendung bei der behandlung von zuständen, die zusammenhängen mit abweichungen bei glutamatergischen übertragungen - Google Patents

1-(adamantyl)amidine und ihre verwendung bei der behandlung von zuständen, die zusammenhängen mit abweichungen bei glutamatergischen übertragungen

Info

Publication number
ATE225768T1
ATE225768T1 AT98959052T AT98959052T ATE225768T1 AT E225768 T1 ATE225768 T1 AT E225768T1 AT 98959052 T AT98959052 T AT 98959052T AT 98959052 T AT98959052 T AT 98959052T AT E225768 T1 ATE225768 T1 AT E225768T1
Authority
AT
Austria
Prior art keywords
treatment
glutamatergic
amidine
adamantyl
transmissions
Prior art date
Application number
AT98959052T
Other languages
English (en)
Inventor
Roger John Gillespie
Michael Fredrick Snape
Simon Edward Ward
Original Assignee
Vernalis Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Res Ltd filed Critical Vernalis Res Ltd
Application granted granted Critical
Publication of ATE225768T1 publication Critical patent/ATE225768T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/16—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT98959052T 1997-12-12 1998-12-11 1-(adamantyl)amidine und ihre verwendung bei der behandlung von zuständen, die zusammenhängen mit abweichungen bei glutamatergischen übertragungen ATE225768T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726388.3A GB9726388D0 (en) 1997-12-12 1997-12-12 Chemical compounds
PCT/GB1998/003715 WO1999031051A1 (en) 1997-12-12 1998-12-11 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission

Publications (1)

Publication Number Publication Date
ATE225768T1 true ATE225768T1 (de) 2002-10-15

Family

ID=10823580

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959052T ATE225768T1 (de) 1997-12-12 1998-12-11 1-(adamantyl)amidine und ihre verwendung bei der behandlung von zuständen, die zusammenhängen mit abweichungen bei glutamatergischen übertragungen

Country Status (9)

Country Link
US (2) US6500866B1 (de)
EP (1) EP1037874B1 (de)
JP (1) JP2002508350A (de)
AT (1) ATE225768T1 (de)
AU (1) AU1498299A (de)
DE (1) DE69808669T2 (de)
ES (1) ES2185237T3 (de)
GB (1) GB9726388D0 (de)
WO (1) WO1999031051A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100504A2 (de) 1998-07-02 2001-05-23 Eisai Co., Ltd. Pharmazeutische zubereitungen und verwendung zur behandlung demyelinisierender erkrankungen
GB9901691D0 (en) 1999-01-26 1999-03-17 Cerebrus Ltd Chemical compounds
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
ITTO20030668A1 (it) 2003-09-02 2005-03-03 Rotta Res Lab S P A O Ra Rottapharm Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione.
TW200531680A (en) * 2004-03-03 2005-10-01 Merz Pharma Gmbh & Co Kgaa Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
HUP0401523A3 (en) * 2004-07-29 2007-05-02 Richter Gedeon Vegyeszet Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
RU2434848C2 (ru) * 2009-11-30 2011-11-27 Учреждение Российской Академии Наук Институт Нефтехимии И Катализа Ран Способ получения 1-хлор-3-цианоадамантана

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE151447C (de)
BE795381A (fr) * 1972-02-15 1973-08-13 Sandoz Sa Derives de l'adamaniane
JPS5246949B2 (de) * 1973-10-19 1977-11-29
DD151447A1 (de) * 1980-06-18 1981-10-21 Heinz Paul Verfahren zur herstellung von amidinen und deren salzen
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases

Also Published As

Publication number Publication date
GB9726388D0 (en) 1998-02-11
AU1498299A (en) 1999-07-05
ES2185237T3 (es) 2003-04-16
EP1037874A1 (de) 2000-09-27
WO1999031051A1 (en) 1999-06-24
JP2002508350A (ja) 2002-03-19
US6500866B1 (en) 2002-12-31
US20030130354A1 (en) 2003-07-10
DE69808669D1 (de) 2002-11-14
EP1037874B1 (de) 2002-10-09
DE69808669T2 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
DE69817802D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE60213452D1 (de) Metallocene und verfahren zur herstellung von propylenpolymeren
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
MX9604430A (es) Tiazolidinas del tipo piridina.
ATE225768T1 (de) 1-(adamantyl)amidine und ihre verwendung bei der behandlung von zuständen, die zusammenhängen mit abweichungen bei glutamatergischen übertragungen
CA2285535A1 (en) Benzimidazole derivative for treating allergy-related disease
NO20003211L (no) Triazinforbindelser for behandling av CNS forstyrrelser
NZ326675A (en) Oxazoline arthropodicides
DE60009263D1 (de) 2-adamantanmethanamin verbindungen zur behandlung von abweichungen bei glutamatergischen übertragungen
DE69902766D1 (de) N-aryloxyethylaminderivate zur behandlung der depression
DE69913652D1 (de) Adamantancarboximidamid-derivate und ihre anwendung als nmda-antagonisten
TW333526B (en) Pesticidal 1-arylpyrazoles
MY101309A (en) Benzoylureas, and their production and use
ES8303308A1 (es) "un procedimiento para preparar derivados de urea y tiourea".
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists
ES2001102A6 (es) Un procedimiento para la preparacion de un derivado de indeno.
GB9801501D0 (en) Chemical compounds - II
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
ES2182775T3 (es) Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion.
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen
TW345579B (en) Cyanoethylmelamine derivatives and method for producing them
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation
AU1898797A (en) Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties